Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Phase I/II study of immunotherapy using autologous tumor lysate-pulsed dendritic cells in patients with metastatic renal cell carcinoma.

Phase I/II study of immunotherapy using autologous tumor lysate-pulsed dendritic cells in patients with metastatic renal cell carcinoma. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Phase I/II study of immunotherapy using autologous tumor lysate-pulsed dendritic cells in patients with metastatic renal cell carcinoma. Abstract Text:

    jung han kimJung Han Kim,yoon leeYoon Lee,yong-soo baeYong-Soo Bae,won seog kimWon Seog Kim,kihyun kimKihyun Kim,ho yeong imHo Yeong Im,won ki kangWon Ki Kang,keunchil parkKeunchil Park,han yong choiHan Yong Choi,hyun moo leeHyun Moo Lee,so-young baekSo-Young Baek,hyunah leeHyunah Lee,hyounmie dohHyounmie Doh,byong-moon kimByong-Moon Kim,chae young kimChae Young Kim,choonju jeonChoonju Jeon,chul won jungChul Won Jung,jung han kimJung Han Kim,yoon leeYoon Lee,yong-soo baeYong-Soo Bae,won seog kimWon Seog Kim,kihyun kimKihyun Kim,ho yeong imHo Yeong Im,won ki kangWon Ki Kang,keunchil parkKeunchil Park,han yong choiHan Yong Choi,hyun moo leeHyun Moo Lee,so-young baekSo-Young Baek,hyunah leeHyunah Lee,hyounmie dohHyounmie Doh,byong-moon kimByong-Moon Kim,chae young kimChae Young Kim,choonju jeonChoonJu Jeon,chul won jungChul Won Jung,jung han kimJung Han Kim,yoon leeYoon Lee,yong-soo baeYong-Soo Bae,won seog kimWon Seog Kim,kihyun kimKihyun Kim,ho yeong imHo Yeong Im,won ki kangWon Ki Kang,keunchil parkKeunchil Park,han yong choiHan Yong Choi,hyun moo leeHyun Moo Lee,so-young baekSo-Young Baek,hyunah leeHyunah Lee,hyounmie dohHyounmie Doh,byong-moon kimByong-Moon Kim,chae young kimChae Young Kim,choonju jeonChoonJu Jeon,chul won jungChul Won Jung,

    This phase I/II study was conducted to evaluate the feasibility, safety and efficacy of immunotherapy using tumor lysate (TL)-pulsed dendritic cells (DC) in patients with metastatic renal cell carcinoma (RCC). DC were generated by culturing peripheral blood mononuclear cells in the presence of GM-CSF and IL-4 and were pulsed with autologous TL and keyhole limpet hemocyanin (KLH). Maturation of DC was induced by a combined treatment of CD40 ligand, IFN and monocyte-conditioned medium. The patients were administered two cycles of TL-pulsed DCs vaccination, each of which comprised of four doses injected subcutaneously at biweekly intervals. Nine patients were included. The immunotherapy was well tolerated without severe side effects. One patient achieved an objective partial response (PR). Five patients showed stable disease (SD), and the remaining three had progressive disease (PD). With a median follow-up of 17.5 months, the median time to progression was 5.2 months and the median overall survival was 29 months. In the antigen-specific lymphocyte proliferation assay, eight patients showed a proliferative response, which tended to be stronger in patients with SD or PR than in patients with PD. The ELISPOT assay was performed in two patients and indicated that one patient with PR showed a much stronger response than another with PD. Our results suggest that TL-pulsed DC immunotherapy in combination with nephrectomy affect the natural course of RCC and are associated with clinical benefits for patients with metastatic diseases.

    Phase I/II study of immunotherapy using autologous tumor lysate-pulsed dendritic cells in patients with metastatic renal cell carcinoma. Publishing Authors By Initials

    jh kimJH Kim,y leeY Lee,ys baeYS Bae,ws kimWS Kim,k kimK Kim,hy imHY Im,wk kangWK Kang,k parkK Park,hy choiHY Choi,hm leeHM Lee,sy baekSY Baek,h leeH Lee,h dohH Doh,bm kimBM Kim,cy kimCY Kim,c jeonC Jeon,cw jungCW Jung,jh kimJH Kim,y leeY Lee,ys baeYS Bae,ws kimWS Kim,k kimK Kim,hy imHY Im,wk kangWK Kang,k parkK Park,hy choiHY Choi,hm leeHM Lee,sy baekSY Baek,h leeH Lee,h dohH Doh,bm kimBM Kim,cy kimCY Kim,c jeonC Jeon,cw jungCW Jung,jh kimJH Kim,y leeY Lee,ys baeYS Bae,ws kimWS Kim,k kimK Kim,hy imHY Im,wk kangWK Kang,k parkK Park,hy choiHY Choi,hm leeHM Lee,sy baekSY Baek,h leeH Lee,h dohH Doh,bm kimBM Kim,cy kimCY Kim,c jeonC Jeon,cw jungCW Jung,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Phase I/II study of immunotherapy using autologous tumor lysate-pulsed dendritic cells in patients with metastatic renal cell carcinoma. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: Clinical immunology (Orlando, Fla.)

    VOLUME: 125

    Page Numbers: 257-67

    Journal Abbreviation: Clin. Immunol.

    ISSN: 1521-6616

    DAY: 3

    MONTH: 10

    YEAR: 2007

    Phase I/II study of immunotherapy using autologous tumor lysate-pulsed dendritic cells in patients with metastatic renal cell carcinoma. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 100883537

    Phase I/II study of immunotherapy using autologous tumor lysate-pulsed dendritic cells in patients with metastatic renal cell carcinoma. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Phase I/II study of immunotherapy using autologous tumor lysate-pulsed dendritic cells in patients with metastatic renal cell carcinoma. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Phase I/II study of immunotherapy using autologous tumor lysate-pulsed dendritic cells in patients with metastatic renal cell carcinoma.

    AFFILIATION: Division of Hematology/Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Ilwon-Dong 50, Gangnam-Gu, Seoul, Korea.

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Clin Immunol

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Phase I/II study of immunotherapy using autologous tumor lysate-pulsed dendritic cells in patients with metastatic renal cell carcinoma Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News